tbuckley/cabot-search huggingface dataset:
Spontaneous Regression of Cancerous Tumors Detected by Mammography Screening—Reply
Authors: Heikki Joensuu, Johan Lundin
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Usefulness of phosphatidylethanol and urinary ethyl glucuronide to monitor alcohol abstinence in patients awaiting liver transplantation
Authors: Olivier Menard, Hakim Florian, Cecile Guenard, Jean Michel Gaulier, Delphine Allorge, Valérie Canva, Lassailly Guillaume, Olivier Cotencin, Alexandre Louvet, Philippe Mathurin, Sebastien Dharancy
Journal: Journal of Hepatology (2020)
AMA Archives Journals Abstracts
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Therapy of impetigo and furunculosis
Authors: W. C. Fritsch
Journal: JAMA (1970)

Pyoderma refers to any purulent disease of the skin, but this communication is restricted to only certain bacterial infections of the skin. Such infections can be either primary or secondary. Although "pyo-" indicates the presence of pus, certain instances of infection may not be pus-producing, for example, staphylococcal bullous impetigo.<sup>1</sup>Nonbacterial, pus-producing skin disease's, such as pustular psoriasis, are not discussed. Impetigo and furunculosis are the most significant bacterial infections of the skin. Chronic, deeper infections, termed ecthyma, probably start as impetigo. Both bacterial folliculitis and carbuncles are anatomical variants of furunculosis. Diffuse interstitial infection is termed cellulitis, and erysipelas is a superficial variant. Almost any dermatosis in which the stratum corneum is broken can become secondarily infected. colonization by pathogens ( coagulase-positive staphylococci and β hemolytic streptococci) is common, but manifest disease is relatively uncommon. There are skin diseases in which bacteria can be recovered from the lesions, but
Financial Incentives
Authors: Stephen E. Silver
Journal: Annals of Internal Medicine (1990)

Letters15 November 1990Financial IncentivesStephen E. Silver, MDStephen E. Silver, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-113-10-808 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editors: Financial incentives are ubiquitous throughout our society, affecting the performance of laborers, tradesmen, and professionals. To what extent do financial incentives determine which parts an auto mechanic replaces or how much time he spends on the job? Do we expect total honesty from an auto mechanic, a plumber, an electrician, or anyone else working on a fee-for-service basis? What makes doctors different?In Alan L. Hillman's editorial on health maintenance organizations, financial incentives, and physicians' judgments, the idea is expressed that using financial incentives to encourage cost-effective care is legitimate. Dr. Hillman states that a relation between...Reference1. Hillman A. Health maintenance organizations, financial incentives, and physicians' judgments [Editorial]. Ann Intern Med. 1990,112:891-3. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: 301 Montauk Avenue New London, CT 06320 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPoint : Does Physician Reimbursement Affect Patient Care? An American Perspective 15 November 1990Volume 113, Issue 10Page: 808-809KeywordsHealth maintenance organizationsMotivation Issue Published: 15 November 1990 PDF downloadLoading ...
From the Centers for Disease Control. Recommendations for the prevention of malaria among travelers
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Comparative Mouse Genomics Centers Consortium (CMGCC): Mouse Models to Improve Understanding of the Biological Significance of Human Polymorphisms
Journal: Environmental Health Perspectives (2005)

The CMGCC is a multidisciplinary, multi-institutional component of the Environmental Genome Project (EGP).This program commenced in 2001 to develop resources in transgenic and knockout mouse models based on single nucleotide polymorphisms (SNPs) in human environmentally responsive genes.The specific goals of the CMGCC are to• identify functional SNPs that are relevant to human environmental health;
SYPHILOPHOBIA.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Increase of oleic acid in erythrocytes associated with malignancies
Authors: N A Habib, C B Wood, K Apostolov
Journal: BMJ (1985)

Total lipid extracts of erythrocyte cell membranes from 60 patients with documented malignancies, 41 patients with various acute and chronic diseases, and 40 healthy subjects were analysed.The results were expressed as ratios of stearic to oleic acid, reflecting the diegree of desaturation of stearic acid.The mean ratios for the healthy subjects and controls without cancer were 1-5 (SD 0 27) and 1 45 (0 28), respectively, whereas the ratios for patients with malignancies were consistently lower than the cut off point of 1-0, with a mean of 0 69 (0-15) (p <0 001).The desaturation ratio was also significantly lower (p <0 001) in the group with recurrent tumours (mean 0 75 (0 04)) compared with those with no evidence of recurrent tumours (mean 1-55 (0 27)).It is suggested that the increased unsaturation (oleic acid) in the circulating erythrocytes may be useful in the diagnosis and postoperative monitoring of patients with cancer.
Medical News
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
StatBite: Reported Cases of Acute Hepatitis Infection in the United States
Journal: JNCI Journal of the National Cancer Institute (2008)

A recent report described the incidence of acute hepatitis infections in the United States.While only a small percentage of acute infections will develop into chronic cases, chronic infection with hepatitis B (HBV) or hepatitis C (HCV) virus is associated with an increased risk of developing liver cancer.An estimated 3.2 million Americans have chronic HCV infections.The report estimated that 46,000 new HBV infections and 19,000 new HCV infections occurred in the U.S. in 2006.These figures were based on the actual number of confirmed cases (4,713 and 802, respectively) plus the estimated number of asymptomatic and unreported cases.
Beauty Patches
Authors: Jorge Roman
Journal: JAMA Dermatology (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
Highlights
Journal: JAMA (2017)

Recent studies have yielded confl icting results about the cardiovascular risks of testosterone therapy.In a trial of 170 men aged 65 years and older with low testosterone levels and symptoms suggestive of hypogonadism, Budoff and colleagues found that treatment with testosterone gel for 1 year compared with placebo was associated with a signifi cantly greater increase in coronary artery noncalcifi ed plaque volume.In an Editorial on this and another article in this issue on testosterone therapy and age-related cognitive function, Handelsman suggests that physicians should consider the cardiovascular risks associated with off -label testosterone use.
Error in Data in Abstract
Authors: Jonathan Santoro, Kelli Paulsen
Journal: JAMA Neurology (2020)

Shima Shahjouei, MD, MPH; Alireza Sadighi, MD; Durgesh Chaudhary, MD; Jiang Li, MD, PhD; Vida Abedi, PhD; Neil Holland, MD; Michael Phipps, MD, MHS; Ramin Zand, MD, MPH
Malignant melanoma and immunotherapy.
Journal: BMJ (1976)

Malignant melanoma and immunotherapyThe sinister reputation of malignant melanoma is not entirely deserved.Surgical management of primary tumours by wide excision and grafting can lead to cure in over half the patients so treated.Nevertheless, any statement about the treatment or prognosis of melanoma must take into account the many variables which affect its clinical behaviour.The three main forms (nodular, superficial-spreading, and lentigo maligna) behave in quite distinct ways.' Furthermore, histological appearance, and especially the depth of invasion of the cutis, is of paramount importance: Clark et al2 showed that melanoma- in-situ (level 1) was associated with a mortality rate of less than 2, whereas deep dermal invasion (level 5) conferred an appalling prognosis.Clinical trials of any form of treatment (including immunotherapy) which do not allow for these and other variables may, and frequently do, present misleading results.Once dissemination has occurred all forms of melanoma appear to enter a final common pathway in which these vari- ables may lose some of their importance.Even so, the final path may take a tortuous and unpredictable route while retaining its inevitable downward trend.Indeed, unpredictabilitv seems to be a cardinal feature ofdisseminated melanoma.Temporary spontaneous regression, apparent stasis for
Medical Education Programs Sponsored by Government Agencies
Journal: JAMA (1987)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Helmets and preventing motorcycle and bicycle injuries: comments and a correction
Authors: P. L. Graitcer
Journal: JAMA (1995)

<h3>In Reply.</h3> —Dr Resnick and colleagues concluded that after a long ride, 70% of 330 bicyclists' helmets did not meet three criteria of a satisfactory fit, mostly because their buckles were not fastened securely. This is somewhat surprising, because bicycle helmets must pass a strap-system integrity test before they are certified by the Snell Memorial Foundation or ANSI.<sup>1</sup>The investigators did not say whether the bicyclists' helmets were certified or whether they might have loosened the straps and buckles during the long, hot ride. Resnick et al state that helmet manufacturers seem to be more concerned with helmet style, weight, and ventilation than with its fit. But those features themselves have much to do with the helmet's acceptability and use by the rider. We agree that bicycle helmets may be difficult to adjust to assure a snug fit. The person who sells the helmet has an obligation to instruct
TISSUE ABNORMALITIES IN HEMOLYTIC ANEMIAS
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BOOK REVIEWS
Journal: JNCI Journal of the National Cancer Institute (1994)

Journal Article BOOK REVIEWS Get access Cancer of the Ovary . Maurie Markman , William J. Hoskins eds. New York : Raven Press , 1993 . 458 pp., illus. $125. Reviewed by John H. Edmonson [J Natl Cancer Inst 85:1246, 1993] JNCI: Journal of the National Cancer Institute, Volume 86, Issue 3, 2 February 1994, Page 235, https://doi.org/10.1093/jnci/86.3.235-a Published: 02 February 1994
Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score
Authors: J Hunter, Jens Kastrup, R Angelo, Palle Petersen, Anders Dejgard
Journal: BMJ (1986)

as distance) is decisive despite the regulations, which are couched as a series of alternatives.2Decisions are made by lay officers interpreting a medical report which pays insufficient attention to assessment of mobility.3This study therefore measured not only aspects of the mobility of holders of the allowance but also the collective opinions ofa group ofassessors.The results should interest organisations representing disabled people.4Most subjects walked more than the 100 m quoted in cases turned down on appeal.They were, however, studied under less stressful and more representative conditions than when being examined for the mobility allowance.The wide scatter ofresults confirms the variability ofassessments and the need to rationalise the system for making the award.It is impossible to set a limiting value for any parameter but the likelihood of an applicant being successful increases as distance, speed, and time ofwalking decrease.I have therefore suggested three categories bounded by distances (120 m, 240 m, and 360 m) and speeds (20 m/min, 34 m/min, and 43 m/min) which might be the basis of a points system.Other parameters of mobility-for example, energy expenditure-would also have to be considered and weighted.The Department of Health and Social Security should commission an independent evaluation ofmethods ofassessing mobility, which would make examinations for the mobility allowance more objective and thereby reduce criticism of this allowance and examining doctors. 1 McGavin CR, Gupta SP, McHardy GJR.Twelve-minute walking test for assessing disability in chronic bronchitis.
Metabolic consequences of salbutamol poisoning reversed by propranolol
Authors: J M C Connell, G T McInnes
Journal: BMJ (1982)

Metabolic consequences of salbutamol poisoning reversed by propranololAdministration of salbutamol, a beta2-adrenoreceptor agonist, is associated with several metabolic consequences including disturbances of carbohydrate, lipid, and potassium homeostasis.5Although the importance of these effects during therapeutic use of the drug is not clear, severe hypokalaemia has been reported after salbutamol poisoning.2As evidence suggests that the metabolic effects are due to beta-adrenoreceptor stimulation3 it seems logical to treat these results of salbutamol poisoning with a beta-adrenergic antagonist.We report a case in which salbutamol-induced hypokalaemia was managed successfully with propranolol. Case reportA previously healthy 17-year-old girl was admitted having taken an unspecified quantity of salbutamol 2 mg tablets (Ventolin) three hours previously.On admission she was agitated and tremulous and had a tachycardia of 156 beats/minute: an electrocardiogram showed the rhythm to be sinus.Blood pressure was 110/60 mm Hg.Gastric lavage was performed with no appreciable tablet return.Initial investigation showed a plasma